If you have questions about side effects, dosing, or which medication is better suited for your specific situation, we are here to offer expert support
14 Little is known about the capacity of exogenously administered GSH, or its precursors, to modify CNS GSH levels
Fat is the primary target
In clinical trials, the 12 mg maintenance dose produced 24.2% body weight loss at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3)
Food remains in the stomach longer, which may help you feel full sooner and stay full longer after eating
I wouldnt recommend semaglutide for AUD in isolation, but if a patient meets BMI or blood sugar criteria for use, and over-drinking is an issue, its a win-win medication, she said